Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > I don't see a mystery

<< Previous

Bullboard Posts

Next >>

Comment by Gman620on Apr 18, 2023 5:10pm

171 Views

Post# 35401667

RE:RE:RE:RE:RE:RE:I don't see a mystery

I don't want to argue against TLT. The discussion was about all kinds of convolution and conspiracy around the stock price dip. A drug that is basically an 'add on' to an existing treatment is much easier to roll out than a completely new approach, drug and process. There are pros and cons. I've had BCG standalone. It sucks. But if they ramp up production, throw on N-803 with those CR percentages, and approval in May, it could have an impact on the stock price short term (or longer, depending).

<< Previous

Bullboard Posts

Next >>

Two micro-cap stocks with strong fundamentals